When we originally introduced the concept of selective replication over two years ago, we had promising ideas and some early data. Today, we have robust experimental results and a much clearer picture of how selective replication can be engineered reliably in RNA viruses. Back then …
My name is Jason, and I’m a product of Southern California, the ’90s, and of course, my parents. I spent most of my childhood playing soccer, whether outside kicking a ball or inside holding an Xbox controller…
Today, we’re thrilled to share a major milestone for Humane Genomics: we’ve partnered with Genezen to begin process transfer and cGMP (Current Good Manufacturing Practice) manufacturing of our lead oncolytic virus candidate for hepatoblastoma. This marks a big step forward in our mission to bring precision-engineered viral therapies to patients with cancer…
Six years ago, I had dinner with my friend and co-founder Andrew Hessel and he told me something that blew my mind: it is possible to 3D print DNA. With this technology, we could engineer viruses for all kinds of purposes. One of the most compelling is to use these viruses as cancer therapies. My […]
Manal Farhat Tell me a bit about yourself. Hi there! I’m Manal, a born and bred New Yorker. Being a true child of the diaspora, I also spent a chunk of my life in Lebanon, my parents’ homeland. I’m a self-professed nerd (and proud), so in retrospect, it doesn’t seem too surprising that I eventually […]
Today, the 2024 Nobel Prize in Medicine was awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNAs (miRNAs). This discovery has transformed our understanding of how cells regulate genes and opened new possibilities for diagnosing and treating diseases. But what exactly are miRNAs, and why are they so significant? What Are […]
We’re thrilled to announce that we’re returning to the American Association for Cancer Research (AACR) annual meeting for the second time! It’s an honor to be invited back to this prestigious event where we’ll be showcasing our groundbreaking work in the field of cancer therapeutics. AACR is the largest gathering of cancer researchers, clinicians, survivors, […]
How viruses infect cells is key to developing safe oncolytic viral therapies. In this post we discuss how viruses can be engineered to target cancer cells. The infection process begins when a virus recognizes and attaches to a host cell. This attachment is typically mediated by viral proteins known as glycoproteins, which specifically bind to […]
We were thrilled to present a poster of our work at AACR. It is one of the biggest conferences on cancer research, with 22,000 visitors. To get accepted, we had to write an abstract, which was reviewed, and we needed to be sponsored by an existing member. For us this was Dr. Sanjeev Vasudevan, whom […]
We are excited to announce we are presenting at the AACR annual meeting for the first time. AACR is the American Association for Cancer Research and its meeting is the largest in the world of cancer research. Last year, over 20,000 scientists, clinicians and other health care professionals, and survivors and patient advocates from around […]